Search - tctmd.com

Displaying 561 - 580 of 733

Sort: Relevancy | Date

News Daily News

与预期相反，研究发现冠状动脉微血管功能障碍无性别差异

Yael L. Maxwell

September 23, 2015

News Daily News

En Contra de lo que cabría Esperar, el Estudio No halla Diferencia de Género en la Disfunción Microvascular Coronaria

Yael L. Maxwell

September 23, 2015

News Daily News

Contrary to Expectations, Study Finds No Sex Difference in Coronary Microvascular Dysfunction

Yael L. Maxwell

September 23, 2015

Presentation

Effect of Sex Differences on Invasive Measures of Coronary Microvascular Dysfunction in Pts With Angina in the Absence of Obstructive CAD

Presenter: Y. Kobayashi

September 22, 2015

News Industry News

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

September 18, 2015

News Daily News

Registry Charts Trends in Mechanical Circulatory Support During PCI

L.A. McKeown

September 14, 2015

News Industry News

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

September 03, 2015

News Conference News ESC 2015

Ezetimibe Benefits Diabetics, and Does Not Increase Risk of New-Onset Diabetes

Yael L. Maxwell

September 01, 2015

News Conference News ESC 2015

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

L.A. McKeown

August 31, 2015

News Industry News

Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes

August 26, 2015

News Industry News

TriVascular Technologies raises $10m, launches study of EVAR in women

August 24, 2015

News Daily News

High Troponin T Foretells Poor Outcomes in Patients With Type 2 Diabetes, Stable Heart Disease

Todd Neale

August 17, 2015

News Daily News

Subestudio del COURAGE: La PCI No Ofrece Beneficio Añadido sobre, Solo, el Tratamiento Médico Óptimo, ni en Hombres ni en Mujeres

L.A. McKeown

August 03, 2015

News Daily News

COURAGE 亚组研究：合并 PCI 并不会改善单纯行 OMT 治疗的女性或男性患者的总体疗效

L.A. McKeown

August 03, 2015

News Daily News

COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men

L.A. McKeown

August 03, 2015

Presentation

COURAGE Substudy: OMT With or Without PCI in Women With Stable Coronary Disease

Presenter: S. Acharjee

July 31, 2015

Advertisement

与预期相反，研究发现冠状动脉微血管功能障碍无性别差异

En Contra de lo que cabría Esperar, el Estudio No halla Diferencia de Género en la Disfunción Microvascular Coronaria

Contrary to Expectations, Study Finds No Sex Difference in Coronary Microvascular Dysfunction

Effect of Sex Differences on Invasive Measures of Coronary Microvascular Dysfunction in Pts With Angina in the Absence of Obstructive CAD

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

Registry Charts Trends in Mechanical Circulatory Support During PCI

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

Ezetimibe Benefits Diabetics, and Does Not Increase Risk of New-Onset Diabetes

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes

TriVascular Technologies raises $10m, launches study of EVAR in women

High Troponin T Foretells Poor Outcomes in Patients With Type 2 Diabetes, Stable Heart Disease

Subestudio del COURAGE: La PCI No Ofrece Beneficio Añadido sobre, Solo, el Tratamiento Médico Óptimo, ni en Hombres ni en Mujeres

COURAGE 亚组研究：合并 PCI 并不会改善单纯行 OMT 治疗的女性或男性患者的总体疗效

COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men

COURAGE Substudy: OMT With or Without PCI in Women With Stable Coronary Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content